eMedicine World Medical Library

Excerpt from Acanthocytosis


Synonyms, Key Words, and Related Terms: acanthocytosis, acanthocytes, abetalipoproteinemia, Bassen-Kornzweig syndrome, atypical retinitis pigmentosa, progressive ataxic neurologic disorder, neuroacanthocytosis, McLeod syndrome, McLeod blood group, Lutheran blood group, apolipoprotein B deficiency, beta-lipoprotein deficiency, beta lipoprotein deficiency, familial hypobetalipoproteinemia, microsomal triglyceride transfer protein deficiency, celiac disease, spur cell hemolytic anemia, spur cell anemia of severe liver disease, severe active hepatitis, cholestasis, neonatal hepatitis, metastatic liver disease

hemochromatosis, Wilson disease, alcoholic cirrhosis, infantile pyknocytosis, Zieve syndrome, lipid metabolism, hypothyroidism, myxedema, chronic granulomatous disease, CGD, hypomagnesemia, hypophosphatemia, uremia, hemolytic anemia, failure to thrive, hepatomegaly, splenomegaly, ascites, metastatic liver disease, hemochromatosis, neonatal hepatitis, cholestasis, Wilson disease, severe acute hepatitis, infantile pyknocytosis

Please click here to view the full topic text: Acanthocytosis

Background

Acanthocytes (from the Greek word acantha, which means thorn), or spur cells, are spiculated red cells with a few projections of varying size and surface distribution. The cells appear contracted, dense, and irregular. The morphology of acanthocytes in these various conditions is similar, but the pathogenesis and clinical context often greatly differ. In general, the formation of acanthocytes depends on alteration of the lipid composition and fluidity of the red cell membrane.

Acanthocytosis is a red cell phenotype associated with various underlying conditions. The most frequent and most significant conditions include abetalipoproteinemia (Bassen-Kornzweig syndrome) and spur cell hemolytic anemia of severe liver disease. Other, less frequent conditions include the following:

  • Neuroacanthocytosis
  • Anorexia nervosa and other malnutrition states
  • Infantile pyknocytosis
  • McLeod syndrome
  • In(Lu) null Lutheran phenotype
  • Hypothyroidism
  • Idiopathic neonatal hepatitis
  • Myxedema
  • Transient hemolysis and stomatocytosis in individuals with alcoholism and mild hemolysis and spherocytosis in individuals with congestive splenomegaly
  • Homozygous familial hypobetalipoproteinemia
  • Zieve syndrome
  • Chronic granulomatous disease (CGD) associated with McLeod red cell phenotype

Acanthocytes should be distinguished from echinocytes (from the Greek word echinos, which means urchin). Echinocytes, or burr cells, appear with multiple small projections that are uniformly distributed on the red cell surface. Echinocytes occur in many conditions, including malnutrition associated with mild hemolysis due to hypomagnesemia and hypophosphatemia, uremia, hemolytic anemia in long-distance runners, and pyruvate kinase deficiency. In vitro, elevated pH, blood storage, ATP depletion, calcium accumulation, and contact with glass can lead to formation of echinocytes.

Pathophysiology

The description of acanthocyte pathophysiology varies depending on the underlying condition. Acanthocytes can be caused by (1) altered distribution or proportions of membrane lipids or by (2) membrane protein or membrane skeleton abnormalities. In membrane lipid abnormalities, previously normal red cell precursors often acquire the acanthocytic morphology from the plasma. Altered membranes may contain decreased phosphatidylcholine levels but increased levels of cholesterol and sphingomyelin. The imbalance in membrane lipids causes cells to stiffen, wrinkle, pucker, and form spicules because of a relative increase of the outer hemileaflet's surface area compared with the inner hemileaflet's surface area. In membrane protein or membrane skeleton abnormalities, the defect is intrinsic but, again, causes imbalances in inner versus outer leaflet surface areas and abnormal interaction between the membrane skeleton and lipid membrane.

The alteration in plasma lipids in autosomal recessive abetalipoproteinemia caused by the absence of beta-apolipoprotein is best described. Specifically, the lipoproteins apoprotein B (ApoB)–48 and ApoB-100 are deficient because of either abnormal assembly or defective aposecretion, leading to absent cellular secretion from hepatocytes or intestinal epithelial cells. Formation of normal chylomicrons (ie, lipoproteins that contain cholesterol and triglycerides) is inhibited and prevents intestinal absorption of lipids, leading to severe fat malabsorption. In addition to lipid abnormalities and altered membrane integrity, red cells have secondary vitamin E–deficiency and develop increased oxidant sensitivity, with a tendency to hemolyze more easily. Acanthocytes in the homozygous form of familial hypobetalipoproteinemia are thought to have a similar pathophysiology.

Severe liver dysfunction of various etiologies can also cause altered plasma lipid composition and acanthocytes (usually called spur cells in this case) because of acquired abnormal red cell membrane lipid composition. The liver dysfunction causes accumulation of an abnormal, apolipoprotein A-II-deficient lipoprotein in plasma. Red cells are loaded with cholesterol by this lipoprotein and acquire an increased cholesterol-to-phospholipid ratio and a surface area preferentially within the outer bilayer leaflet. Cholesterol-laden red cells are then remodeled in the spleen, resulting in the typical spur cell shape. The molecular mechanisms are not completely clear and may also include influences on membrane protein content and functions. The resulting spur cells are less deformable and are easily trapped in the spleen, conferring markedly shortened red cell survival.

Another group of patients with liver dysfunction may have normal red cell membrane lipids, and the pathophysiology in these cases is unknown. This situation is seen more often in children with severe hepatocellular dysfunction.

In neuroacanthocytosis, the plasma lipoproteins are normal, and the formation of acanthocytes may be associated with intrinsic membrane abnormalities. Studies have indicated that abnormal protein formation or abnormal membrane protein trafficking is involved. Electron microscopy studies have shown that membrane protrusions depend on the irregular distribution of the membrane skeletons. Therefore, shape changes are likely related to interactions between membrane skeletons that harbor abnormal proteins and lipid membranes.

These results were also found in acanthocytes due to the McLeod blood group. Individuals with the McLeod blood group or McLeod syndrome lack the Kx antigen, a membrane precursor of the Kell antigen that leads to acanthocytic red cell morphology. The Kell antigen is located on a 93-kD glycoprotein and is associated with the underlying membrane skeleton. Significant ultrastructural variability between cells is observed. McLeod acanthocytes also exhibit increased mechanical stability on ektacytometry findings, increased membrane rigidity, decreased potassium content, and an increased frequency of dense cells. Another blood group phenotype, the null Lutheran blood group or In(Lu) Lu(a-b-) red cell phenotype also causes acanthocytes. However, in both blood groups and in neuroacanthocytosis, cells are more resistant to hemolysis than in the previously mentioned disorders.

Acanthocytes are also found in myxedema, in panhypopituitarism, and in 20-65% of hypothyroidism cases. Serum lipid abnormalities with hypothyroidism are common, and patients with acanthocytes may have more severely abnormal lipids than patients with normal-shaped red cells.

Frequency

International

Acanthocytes are found in 50-90% of cells on peripheral blood smear findings in abetalipoproteinemia, which is a rare autosomal recessive disorder with only about 100 cases described worldwide. Acanthocytes are also relatively common in severe liver dysfunction and malnutrition. Spur cell hemolytic anemia of severe liver disease is an uncommon complication and depends on the incidence of the underlying hepatic or hepatotoxic disorder. It occurs most often in patients with alcoholic cirrhosis, which develops in 10-30% of all patients with alcoholism (approximately 10 million in the United States).

The percentage of acanthocytes is usually smaller in the rare conditions of neuroacanthocytosis and McLeod and null Lutheran red cell blood group abnormalities. In hypothyroidism, 20-65% of cases have approximately 0.5-2% acanthocytes on peripheral smear findings.

Mortality/Morbidity

Mortality and morbidity with acanthocytosis due to abetalipoproteinemia is not well described because of the rarity of the disease and the limited prognostic data. Lifespan may be near normal with early diagnosis and adequate vitamin supplementation and dietary restriction but may vary significantly. Death may occur in the second or third decade and is usually determined by the degree and progression of neurological complications. Acanthocytosis due to severe liver dysfunction is a hallmark of high risk for mortality. In neonatal hepatitis, the process resolves in 65% of individuals within weeks to months. Acanthocytosis in infantile pyknocytosis is a transient benign process. In malnutrition, hypothyroidism, and myxedema, the red cell abnormality resolves with appropriate treatment and resolution of the underlying disease.

Race

Acanthocytosis within the various underlying conditions is seen in all ethnicities.

Sex

Acanthocytosis has no sex predominance.

Age

The appearance of acanthocytes depends on the underlying condition. Acanthocytes in infants and children may indicate infantile pyknocytosis, neonatal hepatitis, autosomal recessive abetalipoproteinemia or homozygous familial hypobetalipoproteinemia, McLeod blood group, null Lutheran blood group, CGD with McLeod blood group, hypothyroidism, or severe malnutrition.

Please click here to view the full topic text: Acanthocytosis

About Us | Privacy | Code of Ethics | Terms of Use | Contact Us | Advertising | Institutional Subscribers
Labelled with ICRA © 1996-2006 by WebMD.
All Rights Reserved.

Medicine is a constantly changing science and not all therapies are clearly established. New research changes drug and treatment therapies daily. The authors, editors, and publisher of this journal have used their best efforts to provide information that is up-to-date and accurate and is generally accepted within medical standards at the time of publication. However, as medical science is constantly changing and human error is always possible, the authors, editors, and publisher or any other party involved with the publication of this article do not warrant the information in this article is accurate or complete, nor are they responsible for omissions or errors in the article or for the results of using this information. The reader should confirm the information in this article from other sources prior to use. In particular, all drug doses, indications, and contraindications should be confirmed in the package insert. FULL DISCLAIMER